Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

691 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
EANM procedure guidelines for radionuclide therapy with 177Lu-labelled PSMA-ligands (177Lu-PSMA-RLT).
Kratochwil C, Fendler WP, Eiber M, Baum R, Bozkurt MF, Czernin J, Delgado Bolton RC, Ezziddin S, Forrer F, Hicks RJ, Hope TA, Kabasakal L, Konijnenberg M, Kopka K, Lassmann M, Mottaghy FM, Oyen W, Rahbar K, Schöder H, Virgolini I, Wester HJ, Bodei L, Fanti S, Haberkorn U, Herrmann K. Kratochwil C, et al. Among authors: oyen w. Eur J Nucl Med Mol Imaging. 2019 Nov;46(12):2536-2544. doi: 10.1007/s00259-019-04485-3. Epub 2019 Aug 22. Eur J Nucl Med Mol Imaging. 2019. PMID: 31440799
Clinical radionuclide therapy dosimetry: the quest for the "Holy Gray".
Brans B, Bodei L, Giammarile F, Linden O, Luster M, Oyen WJG, Tennvall J. Brans B, et al. Among authors: oyen wjg. Eur J Nucl Med Mol Imaging. 2007 May;34(5):772-786. doi: 10.1007/s00259-006-0338-5. Eur J Nucl Med Mol Imaging. 2007. PMID: 17268773 Free PMC article. Review.
EANM procedure guideline for radio-immunotherapy for B-cell lymphoma with 90Y-radiolabelled ibritumomab tiuxetan (Zevalin).
Tennvall J, Fischer M, Bischof Delaloye A, Bombardieri E, Bodei L, Giammarile F, Lassmann M, Oyen W, Brans B; Therapy Committee, EANM; Oncology Committee, EANM; Dosimetry Committee, EANM. Tennvall J, et al. Among authors: oyen w. Eur J Nucl Med Mol Imaging. 2007 Apr;34(4):616-22. doi: 10.1007/s00259-007-0372-y. Eur J Nucl Med Mol Imaging. 2007. PMID: 17323056
Guidelines for radioiodine therapy of differentiated thyroid cancer.
Luster M, Clarke SE, Dietlein M, Lassmann M, Lind P, Oyen WJ, Tennvall J, Bombardieri E; European Association of Nuclear Medicine (EANM). Luster M, et al. Among authors: oyen wj. Eur J Nucl Med Mol Imaging. 2008 Oct;35(10):1941-59. doi: 10.1007/s00259-008-0883-1. Eur J Nucl Med Mol Imaging. 2008. PMID: 18670773
FDG PET and PET/CT: EANM procedure guidelines for tumour PET imaging: version 1.0.
Boellaard R, O'Doherty MJ, Weber WA, Mottaghy FM, Lonsdale MN, Stroobants SG, Oyen WJ, Kotzerke J, Hoekstra OS, Pruim J, Marsden PK, Tatsch K, Hoekstra CJ, Visser EP, Arends B, Verzijlbergen FJ, Zijlstra JM, Comans EF, Lammertsma AA, Paans AM, Willemsen AT, Beyer T, Bockisch A, Schaefer-Prokop C, Delbeke D, Baum RP, Chiti A, Krause BJ. Boellaard R, et al. Eur J Nucl Med Mol Imaging. 2010 Jan;37(1):181-200. doi: 10.1007/s00259-009-1297-4. Eur J Nucl Med Mol Imaging. 2010. PMID: 19915839 Free PMC article.
111In-pentetreotide scintigraphy: procedure guidelines for tumour imaging.
Bombardieri E, Ambrosini V, Aktolun C, Baum RP, Bishof-Delaloye A, Del Vecchio S, Maffioli L, Mortelmans L, Oyen W, Pepe G, Chiti A; Oncology Committee of the EANM. Bombardieri E, et al. Among authors: oyen w. Eur J Nucl Med Mol Imaging. 2010 Jul;37(7):1441-8. doi: 10.1007/s00259-010-1473-6. Eur J Nucl Med Mol Imaging. 2010. PMID: 20461371
Dosimetric analysis of 177Lu-cG250 radioimmunotherapy in renal cell carcinoma patients: correlation with myelotoxicity and pretherapeutic absorbed dose predictions based on 111In-cG250 imaging.
Stillebroer AB, Zegers CM, Boerman OC, Oosterwijk E, Mulders PF, O'Donoghue JA, Visser EP, Oyen WJ. Stillebroer AB, et al. J Nucl Med. 2012 Jan;53(1):82-9. doi: 10.2967/jnumed.111.094896. Epub 2011 Dec 12. J Nucl Med. 2012. PMID: 22159179 Free article. Clinical Trial.
Predictive patient-specific dosimetry and individualized dosing of pretargeted radioimmunotherapy in patients with advanced colorectal cancer.
Schoffelen R, Woliner-van der Weg W, Visser EP, Goldenberg DM, Sharkey RM, McBride WJ, Chang CH, Rossi EA, van der Graaf WT, Oyen WJ, Boerman OC. Schoffelen R, et al. Among authors: oyen wj. Eur J Nucl Med Mol Imaging. 2014 Aug;41(8):1593-602. doi: 10.1007/s00259-014-2742-6. Epub 2014 Mar 19. Eur J Nucl Med Mol Imaging. 2014. PMID: 24643780 Clinical Trial.
691 results